Log in to save to my catalogue

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived...

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2411938504

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

About this item

Full title

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2020-06

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Gastrointestinal symptoms in COVID-19 are associated with prolonged symptoms and increased severity. We employed human intestinal organoids derived from pluripotent stem cells (PSC-HIOs) to analyze SARS-CoV-2 pathogenesis and to validate efficacy of specific drugs in the gut. Certain, but not all cell types in PSC-HIOs express SARS-CoV-2 entry fact...

Alternative Titles

Full title

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2411938504

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2411938504

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2020.06.10.144816